From Name

From Email

To Name

To Email

Message

Novo Nordisk and Evotec Partner to Develop Therapies for Chronic Kidney Disease

from BioSpace

Novo Nordisk and Evotec Partner to Develop Therapies for Chronic Kidney Disease BioSpace Germany's Evotec and Denmark's Novo Nordisk are partnering to discover and develop new therapies for chronic kidney disease. Together the two companies will scour comprehensive medical and molecular data sets of thousands of chronic kidney disease patients to identify and then develop possible drugs. READ MORE

more